NCT03241836

Brief Summary

Pelvic floor failure is a common disorder that can seriously jeopardize woman's quality of life by causing urinary, fecal incontinence, difficult defecation and pelvic pain. Multiple congenital and acquired risk factors are associated with pelvic floor failure including altered collagen metabolism, female sex, vaginal delivery, menopause, and advanced age. A complex variety of fascial and muscular lesions that range from stretching, insertion detachment, denervation atrophy, and combinations of pelvic floor relaxation to pelvic organ prolapse may manifest in a single patient. The prevalence of pelvic floor dysfunction increases with age. It is approximately 9.7% in child bearing period (20-39 yrs), while it reaches up to 49.7% by 80 yrs and older. Thorough preoperative assessment of pelvic floor failure is necessary to reduce the rate of relapse, which is reported to be as high as 30%. MR imaging is a powerful tool that enables radiologists to comprehensively evaluate pelvic anatomic and functional abnormalities, thus helping surgeons provide appropriate treatment and avoid repeat operations. Real time 2D trans-perineal ultrasound is emerging as an exciting new technique for pelvic floor assessment. It has advantage of providing a global view of the entire pelvic floor, from the symphysis to the ano-rectum, and includes the lower aspects of the levator ani muscle, in addition to its lower costs and greater accessibility; also sonographic imaging is more useful in the clinical environment, and generally better tolerated than MRI.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2018

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

February 27, 2018

Status Verified

February 1, 2018

Enrollment Period

1.9 years

First QC Date

August 1, 2017

Last Update Submit

February 24, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • accuracy of trans-perineal ultrasonography in assessment of pelvic floor dysfunction

    four years

Interventions

accuracy of trans perineal ultrasonography in identification of female pelvic floor dysfunction

Also known as: dynamic pelvic MRI

Eligibility Criteria

Age20 Years - 39 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

female patients in child bearing period (20-39 yrs old) with or without symptoms of pelvic floor failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • alzahraa sayed hassan, a.lecturer

    Assiut University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

August 1, 2017

First Posted

August 8, 2017

Study Start

May 1, 2018

Primary Completion

April 1, 2020

Study Completion

April 1, 2022

Last Updated

February 27, 2018

Record last verified: 2018-02